DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,300 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices.
Summary for Tradename: DATSCAN
Clinical Trials for: DATSCAN
Diagnostic of Lewy Body Dementia by Combining Scintigraphy (SPECT) Using a Specific Transporter and Magnetic Resonance Imaging (MRI)
Status: Completed Condition: Lewy Body Dementia
DaTSCAN Imaging in Aging and Neurodegenerative Disease
Status: Enrolling by invitation Condition: Dementia; Parkinsonism; Mild Cognitive Impairment
A Study to Assess Changes in Clinical Management After DaTSCAN Imaging of Subjects With Clinically Uncertain Parkinsonism or an Illness With Similar Symptoms
Status: Completed Condition: Parkinsonian Syndromes
Imaging of Vesicular Acetylcholine and Dopamine Transporters in Dementia With Lewy Bodies
Status: Recruiting Condition: Dementia With Lewy Bodies
Study of Dopamine and Serotonin Transporters in Patients With Amyotrophic Lateral Sclerosis and Controls
Status: Recruiting Condition: Amyotrophic Lateral Sclerosis
Dopaminergic Loss and Pain in Parkinson's Disease
Status: Completed Condition: Parkinson's Disease; Pain
Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia
Status: Completed Condition: Lewy Body Dementia; Non-DLB Dementia; Alzheimer’s; Vascular Dementia
Imaging Biomarkers of Delayed Sequelae in Trauma Brain Injury
Status: Enrolling by invitation Condition: Traumatic Brain Injury; Parkinson's Disease
Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease
Status: Completed Condition: Parkinson Disease; Parkinsonian Syndrome
Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients' First Degree Relatives
Status: Not yet recruiting Condition: Parkinson Disease
Courtesy of ClinicalTrials.org
See more clinical trials for this drug
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Type||RLD||Patent No.||Product||Substance||Delist_Flag||Patent Expiration||Exclusivity Expiration|
Ge Hlthcare Inc
|SOLUTION; INTRAVENOUS||022454||Jan 14, 2011||RX||Yes||<disabled>||<disabled>|
Ge Hlthcare Inc
|SOLUTION; INTRAVENOUS||022454||Jan 14, 2011||RX||Yes||5,310,912||Y||<disabled>||<disabled>|
|The preview shows a limited data set. Complete access is available with a Subscription|
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639`abc